Serum hyaluronate in primary biliary cirrhosis–a biochemical marker for progressive liver damage
The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.
Abstract
To evaluate serum hyaluronate as a marker for progressive liver injury in patients with primary biliary cirrhosis, a longitudinal study including 48 patients was conducted with a mean follow-up time of 40 months. The patients were examined every 6 months with a standardized set of conventional liver function tests, and a liver biopsy was performed every year. The hyaluronate concentration correlated significantly (p < 0.001) with albumin, t 1/2 galactose tolerance test, bilirubin and prothrombin time but not to serum variables reflecting inflammatory activity. Furthermore, there was a close correlation between serum hyaluronate levels and histopathological changes in the liver. The hyaluronate concentration increased significantly over time in all clinical stages of primary biliary cirrhosis (p < 0.01), whereas the conventional liver function tests only changed in the advanced cases. The present data indicate that serum hyaluronate may be a sensitive marker for progressive liver damage in primary biliary cirrhosis. Serial determinations of hyaluronate are therefore of potential value for monitoring liver function during clinical management of the condition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hyaluronic acid was the first marker to show significant association with clinical outcomes [81,82].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [81]
In the citing paper
“Hyaluronic acid was the first marker to show significant association with clinical outcomes [81,82].”
From EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. (2017) · cites this paper as [81]
Citations
Cites
Kaplan, M. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702263160907 · Cited by 1,959
Roll, J., Boyer, J. L., Barry, D., & Klatskin, G. (1983) · New England Journal of Medicine · doi:10.1056/nejm198301063080101 · Cited by 417 · cited 1×
“Although several reports indicate a good general prognosis for these cases (2), the progress of the disease is variable and unpredictable in each individual case (3).”
BackgroundStudies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells
Smedsrød, B., Pertoft, H., Eriksson, S., Fraser, J. R. E., & Laurent, T. C. (1984) · Biochemical Journal · doi:10.1042/bj2230617 · Cited by 297
Increased Serum Levels of Hyaluronate in Liver Disease
Engström-Laurent, A., Lööf, L., Nyberg, A., & Schröder, T. (1985) · Hepatology · doi:10.1002/hep.1840050420 · Cited by 243
Self-citationConcentration of sodium hyaluronate in serum
Engström-Laurent, A., Laurent, U. B. G., Lilja, K., & Laurent, T. C. (1985) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518509155249 · Cited by 228
Engström-Laurent, A., & Hällgren, R. (1985) · Annals of the Rheumatic Diseases · doi:10.1136/ard.44.2.83 · Cited by 204
ELIMINATION OF HYALURONIC ACID FROM THE BLOOD STREAM IN THE HUMAN
Fraser, J. R. E., Laurent, T. C., Engström‐Laurent, A., & Laurent, U. G. B. (1984) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1984.tb00235.x · Cited by 192
Asymptomatic primary biliary cirrhosis
Beswick, D. R., Klatskin, G., & Boyer, J. L. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90325-7 · Cited by 152
Engströum‐Laurent, & Hällgren, R. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780301203 · Cited by 134
Beswick, D. R., Klatskin, G., & Boyer, J. L. (1985) · PubMed · Cited by 117
Research works printed but not linked: 4
- James, 1981, Lancet, 1, 1278
- Scheuer, 1967, Proc R Soc Med, 60, 1257
- Fraser, 1986, J Lab Clin Med, 107, 79
- Sherlock, 1982, Scand J Gastroenterol, 17, 63
Cited by
Items 101–141 of 141
Chongsrisawat, V., Kongtawelert, P., Tongsoongnoen, W., Tangkijvanich, P., Vejchapipat, P., & Poovorawan, Y. (2004) · Pediatric Surgery International · doi:10.1007/s00383-004-1141-7 · Cited by 14
Serum surrogate markers of liver fibrosis in primary biliary cirrhosis
Voumvouraki, A., Koulentaki, M., Notas, G., Sfakianaki, O., & Kouroumalis, E. (2010) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2010.10.002 · Cited by 13
Increased ascitic level of hyaluronan in liver cirrhosis
Lai, K. N., Szeto, C. C., Lam, C. W. K., Lai, K. B., Wong, T. Y. H., & Leung, J. C. K. (1998) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(98)90186-x · Cited by 13
Uchida, K., Inoue, M., Otake, K., Yoshiyama, S., Toiyama, Y., Hiro, J., Araki, T., Miki, C., & Kusunoki, M. (2006) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2006.05.058 · Cited by 12
Mathurin, P., & Poynard, T. (2004) · Wiley eBooks · doi:10.1002/9780470987025.ch25 · Cited by 12
Current research of hepatic cirrhosis in China
Yao, X., shu-lin, J., & Yao, D.-M. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i5.617 · Cited by 11
Usunobun, U., & Okolie, N. P. (2016) · International Journal of Medicine · doi:10.14419/ijm.v4i1.5784 · Cited by 10
Yamashita, Y., Shiota, A., Fujise, N., OGAWA, H., Masunaga, H., Yasuda, H., & Higashio, K. (1998) · Journal of Veterinary Medical Science · doi:10.1292/jvms.60.359 · Cited by 10
Hyaluronan as a Clinical Marker
Engström‐Laurent, A., & Laurent, T. C. (1989) · Elsevier eBooks · doi:10.1016/b978-0-12-450740-1.50023-8 · Cited by 10
Role of Endothelin in Obstructive Jaundice
Šarac, A., Aktan, A. O., Moini, H., Bilsel, S., & Scapa, E. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026614803584 · Cited by 10
Predicting the prognosis of primary biliary cirrhosis.
Neuberger, J. (1989) · Gut · doi:10.1136/gut.30.11.1519 · Cited by 9
Evaluation of various models of hyaluronan kinetics for assessment of liver function
Lindqvist, U. R. C., Groth, T., & Lebel, L. (1997) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365519709057818 · Cited by 9
Hyaluronidase activity in serum of patients with monoclonal gammapathy
Laudat, A., Guechot, J., Lecourbe, K., Damade, R., & Palluel, A.-M. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(00)00348-x · Cited by 8
Current and emerging surrogate markers of hepatic fibrosis in primary biliary cirrhosis
Talwalkar, J. A. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01761.x · Cited by 8
Mattsson, L., Lindqvist, U. R. C., Weiland, O., & Åberg, B. (1990) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549009023113 · Cited by 7
Nakano, H., OKAMOTO, Y., Nakabayashi, H., Takamatsu, S., Tsujii, H., & MATSUOKA, H. (1996) · International Hepatology Communications · doi:10.1016/0928-4346(96)00292-7 · Cited by 6
Automated assay of hyaluronic acid in serum
Guechot, J., Edrief, S., Lasnier, E., & Küper, R. (2008) · Immuno-analyse & Biologie Spécialisée · doi:10.1016/j.immbio.2008.02.011 · Cited by 6
Neuberger, J. M., & Adams, D. (1989) · Baillière s Clinical Gastroenterology · doi:10.1016/0950-3528(89)90054-7 · Cited by 6
Chronic Non-A, Non-B Hepatitis with Special Reference to the Transfusion-Associated Form
Mattsson, L. (1988) · Scandinavian Journal of Infectious Diseases · doi:10.3109/inf.1988.20.suppl-59.01 · Cited by 6
Non‐invasive means to study the functional status of sinusoidal liver endothelial cells
Smedsrød, B. H. (1995) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1995.tb01807.x · Cited by 6
Primary biliary cirrhosis: the future
Mayo, M. J. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00093-x · Cited by 6
Moghaddam, F. M., Arrbabi, H., & Khajedaloei, M. (2010) · PubMed Central · Cited by 5
Takei, Y., Honma, T., & Ito, A. (2002) · Journal of Immunoassay and Immunochemistry · doi:10.1081/ias-120002276 · Cited by 5
Liver transplantation and primary biliary cirrhosis
Burroughs, A. K., Biagini, M. R., McCormick, P. A., & Rolles, K. (1989) · Postgraduate Medical Journal · doi:10.1136/pgmj.65.766.553 · Cited by 5
Serum hyaluronate in patients with acute and fulminant hepatitis
Suzuki, K., Endo, R., Takikawa, Y., Nakadate, I., & Sato, S. (1996) · Journal of Gastroenterology · doi:10.1007/bf02389523 · Cited by 5
Azer, S. A., McCaughan, G. W., & Stacey, N. H. (1997) · Springer eBooks · doi:10.1007/978-3-662-12385-0_14 · Cited by 4
Romeo, M., Nardo, F. D., Basile, C., Napolitano, C., Vaia, P., Martinelli, G., Gregorio, A. D., Puorto, L. D., Indipendente, M., Dallio, M., et al. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15120597 · Cited by 3
CLINICAL APPLICATION OF SERUM HYALURONAN FOR LIVER DISEASES AND ITS SIGNIFICANCE
Ueno, T., Hashimoto, O., Tamaki, S., Ogata, T., Nakamura, T., Sakata, R., Tanikawa, K., & Sata, M. (2002) · Elsevier eBooks · doi:10.1533/9781845693121.445 · Cited by 2
Akram, M., Memon, A. R., Pushpa, Farman, F. U., & Shafiq, M. I. (2018) · Journal of Liaquat University of Medical & Health Sciences · doi:10.22442/jlumhs.181730570 · Cited by 1
Liver Injury and Serum Hyaluronan
Ueno, T., & Tanikawa, K. (1997) · Springer eBooks · doi:10.1007/978-3-662-12385-0_6 · Cited by 1
Serum hyaluronate level correlates to the degree of liver fibrosis in pediatric liver diseases
Nakashima, E. (1999) · Hepatology Research · doi:10.1016/s1386-6346(99)00039-x · Cited by 1
Marqueurs périphériques, perspectives d'avenir
Schellenberg, F., & Nalpas, B. (2001) · Pathologie Biologie · doi:10.1016/s0369-8114(01)00240-1
Transplantation for autoimmune liver disease
Neuberger, J. (2000) · Springer eBooks · doi:10.1007/978-94-011-4000-3_31
The Significance of Ischemic Tolerance in Severe Liver Ischemia / Reperfusion Injury
Sakurai, H., NOGUCHI, T., ITO, I., & Sakaida, M. (2003) · Thermal Medicine(Japanese Journal of Hyperthermic Oncology) · doi:10.3191/thermalmedicine.19.31
Γλυκοζαμινογλυκάνες στο γενικό πληθυσμό
Παπαναστασοπούλου, Χ. (2016) · doi:10.12681/eadd/39505
Comparative study of anti-hepatofibr-otic effect of tetrandrine, rhubarb and dipyridamole
Wang, R., Chen, Y., Wei, X.-G., Xu, Q., & Li, D. (2003) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v11.i10.1492
Risk stratification in primary biliary cholangitis and primary sclerosing cholangitis
Goet, J. C. (2021) · EUR Research Repository (Erasmus University Rotterdam)
Sakugawa, H., Nakasone, H., Kawakami, Y., Nakayoshi, T., Kinjo, F., Saitô, A., Ikema, M., Yamashiro, A., & Nakayoshi, T. (1995) · 琉球医学会誌 = Ryukyu Medical Journal
Transplantation for autoimmune liver diseases
Neuberger, J. (2007) · Springer eBooks · doi:10.1007/1-4020-2914-4_23
原発性胆汁性肝硬変のUrsodeoxycholic acid(UDCA)治療
竹崎, 英., 村上, 信., 敏孝, 津., 水野, 重., 恵, 久., 佐野村, 誠., & Morihara, M. (1999) · 医療 · doi:10.11261/iryo1946.53.504
Metadata
- Authors
- Nyberg, A., Engström-Làurent, A., & Lööf, L.
- Affiliations
- Uppsala University Hospital (SE)
- Corresponding author
- Nyberg, Anders
- ORCID
- Nyberg, Anders
- Venue
- Hepatology
- Published
- 1988-01
- Volume
- 8
- Issue
- 1
- Pages
- 142-146
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2073402254
- Semantic Scholar
- b93d1eecf8d27c66ec88414c008cc1e9651e67a5
- Cited by
- 134
- References
- 18
- Citations by year
- 2025: 1 · 2023: 1 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 4 · 2015: 4 · 2012: 1
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 10105 d)
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- primary biliary cirrhosis, biochemical markers, liver function monitoring, liver histopathology, liver biopsy, serum albumin, prothrombin time, bilirubin, galactose tolerance test
- MeSH terms
- Biopsy, Female, Follow-Up Studies, Humans, Hyaluronic Acid, Liver, Liver Cirrhosis, Biliary, Liver Function Tests, Longitudinal Studies, Male, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.